Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review

Since their approval by the Food and Drug Administration (FDA) in 1989, proton pump inhibitors (PPIs) have become one of the most highly utilized drugs in the United States, assuming a position as one of the top 10 most prescribed medications in the country. The purpose of PPIs is to limit the amoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Edinoff, Amber N., Wu, Natalie W., Parker, Katelyn, Dudossat, Edwin, Linquest, Lauren, Flanagan, Chelsi J., Dharani, Anam, Patel, Hirni, Willett, Olga, Cornett, Elyse M., Kaye, Adam M., Kaye, Alan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157135/
https://www.ncbi.nlm.nih.gov/pubmed/37140707
http://dx.doi.org/10.1007/s12325-023-02476-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157135/
https://www.ncbi.nlm.nih.gov/pubmed/37140707
http://dx.doi.org/10.1007/s12325-023-02476-3

Ejemplares similares